WP1 Scientific Excellence
WP1 leader: Prof. Dr.sc.ing. Dagnija Loca
WP1 increases scientific excellence through improved research outcomes, elevating the impact factor, number of peer-reviewed publications and Hirsch index. Furthermore, WP1 objective is to build a research excellence of highly qualified human resources and promote international collaborations in the field of biomaterials for bone regeneration.
BBCE scientific groups
Group 1 – Calcium phosphates and composites (responsible partner: RTU RBIDC)
Group 2 – Drug/ion/cell delivery (responsible partner: RTU RBIDC).
Group 3 – Materials in vitro (responsible partner: RTU RBIDC).
Group 4 – Kinetics and stability of drug delivery systems (responsible partner: RSU FDF).
Group 5 – Preclinical biomaterial evaluation (responsible partner: LIOS LPP).
Group 6 - Clinical evaluation of materials and personalized implant development (responsible partner: RSU IS).
BBCE project´s main objective is to establish a joint Baltic Biomaterials Centre of Excellence for advanced biomaterials development based on the long-term strategic cooperation between AO Research Institute Davos, Switzerland (ARI) and Friedrich-Alexander University of Erlangen-Nuremberg, Germany (FAU) on the one hand and RTU RBIDC, LIOS, RSU and RSU IS on the other hand.
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 857287